Hello, Fool! | Login | Signup | My Fool
Aug 30, 2008 5:39 AM ET | Site Changes | Help
The Company is a science-driven, biopharmaceutical company that seeks to discover, develop, and commercialize therapeutics for major medical needs in the areas of neurological and inflammatory diseases.
View All Commentary (RNVS)
Recs
cramersaprentice (< 20) Submitted: 10/26/06 5:34 PM : Start Price: $3.51 RNVS Score: -33.10
this stock has been plastered and all the possible negitive news that is possible is out this one will move higher in the coming months
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK